Photon-Counting CT Does Not Replace Cleerly. It May Make It Better.
Photon-counting CT is attracting attention because it may solve some of the persistent problems in cardiac imaging. It can produce sharper images, reduce the visual distortion caused by dense calcium and improve the ability to see through or around coronary stents and other metal devices. This could make a coronary CT angiogram more accurate in patients whose arteries are difficult to evaluate with conventional CT.
Cleerly serves a different purpose. It does not perform the scan. It analyzes CCTA images to calculate the amount and type of coronary plaque, estimate the severity of narrowing and, when specifically ordered, evaluate the likelihood of ischemia.
The practical comparison is therefore not photon-counting CT versus Cleerly. One improves image acquisition; the other extracts and organizes clinical information from those images. In principle, clearer source images could improve advanced plaque analysis. However, software platforms must be properly validated on photon-counting datasets before measurements from different scanner technologies are assumed to be interchangeable.
Photon-counting CT is promising, especially for heavily calcified arteries and coronary stents. It does not make every existing CCTA obsolete, and it does not replace clinical judgment. For many patients, a well-performed conventional CCTA followed by experienced interpretation or Cleerly analysis remains a useful and appropriate option.
Medical technology has a habit of arriving with language that makes everything before it sound outdated. Photon-counting computed tomography may eventually justify some of that enthusiasm, particularly in cardiac imaging. It represents a meaningful improvement in how CT images can be acquired.
It should not, however, be confused with Cleerly.
A photon-counting scanner creates the images. Cleerly analyzes images that have already been created. They address different parts of the same process, and the most useful question is not which one wins. It is whether better image acquisition can make advanced coronary plaque analysis more accurate and clinically useful.
What Is Photon-Counting CT?
Most conventional CT scanners use energy-integrating detectors. These detectors collect the combined energy deposited by many X-ray photons and convert it into an image.
Photon-counting detectors work differently. They detect individual X-ray photons and measure information about their energy. This allows the scanner to generate high-resolution images while also gathering spectral information that may help distinguish materials such as calcium, iodine and metal.
In practical terms, photon-counting CT may offer:
- Improved spatial resolution
- Lower image noise at comparable resolution
- Greater iodine contrast
- Potential reductions in radiation or contrast dose
- Less distortion from dense coronary calcium
- Better visualization around coronary stents and implanted devices
These advantages are especially relevant in coronary imaging, where a very small vessel lumen can be obscured by calcium or metal.
The Calcium Blooming Problem
Coronary calcium can appear larger on a CT image than it really is. This is called calcium blooming. Dense calcium may spread visually into the vessel opening, making the remaining lumen look smaller and the narrowing look worse.
This can make a conventional CCTA more difficult to interpret in patients with high calcium scores. In some cases, the scan may suggest severe stenosis when the actual narrowing is less substantial. In others, the lumen may be too obscured for confident evaluation.
Photon-counting CT may reduce this blooming effect through higher spatial resolution and sharper reconstruction. That could allow clinicians to see more of the vessel opening instead of primarily seeing the surrounding calcium.
This does not mean calcium is harmless. It means the scanner may become better at distinguishing the calcium from the lumen that remains.
What Does Cleerly Do?
Cleerly is not a CT scanner and it does not acquire images. A patient first undergoes a coronary CT angiogram at an imaging facility. The resulting images can then be submitted for Cleerly analysis.
Cleerly uses artificial intelligence and quantitative image analysis to evaluate findings that may include:
- Total coronary plaque burden
- Calcified plaque
- Noncalcified plaque
- Low-density or potentially higher-risk plaque characteristics
- The location and severity of coronary narrowing
- Changes in plaque burden when comparable serial studies are available
- The likelihood of vessel-specific ischemia when the separate ischemia analysis is ordered
The value is not merely that Cleerly produces another picture. It converts the CCTA into a structured assessment of how much coronary disease is present, where it is located and what kind of plaque is contributing to the burden.
Photon-Counting CT Versus Cleerly
| Photon-Counting CT | Cleerly |
|---|---|
| CT scanner and detector technology | CCTA analysis software |
| Acquires the coronary images | Analyzes images after acquisition |
| May improve resolution and reduce artifacts | Quantifies plaque, composition and stenosis |
| May be especially useful with heavy calcium or stents | May provide a more complete assessment of coronary disease burden |
| Availability depends on the imaging center | Requires a compatible, technically adequate CCTA |
A patient would not ordinarily choose Cleerly instead of photon-counting CT. The more relevant comparison is between a conventional CCTA and a photon-counting CCTA, either of which may potentially be followed by advanced analysis when the images and software are compatible.
Could Photon-Counting CT Make Cleerly Better?
Possibly, but this should not be assumed without validation.
Artificial intelligence can only analyze the data it receives. Images with clearer vessel boundaries and less calcium blooming could theoretically improve measurements of the lumen, stenosis and plaque. Photon-counting CT may therefore provide better raw material for advanced plaque analysis.
At the same time, a change in scanner technology can affect image texture, spatial resolution, reconstruction settings and apparent plaque volume. An algorithm trained and validated primarily on conventional CT images may not automatically produce identical measurements when given a photon-counting dataset.
Software developers and imaging centers will need to verify that plaque measurements, stenosis estimates and ischemia calculations remain accurate and reproducible. A sharper image is valuable, but it does not eliminate the need to validate what the software does with it.
Could a CAC Score of Zero Become Nonzero?
Photon-counting CT may detect smaller calcium deposits than conventional scanners. In some patients, a calcium score previously reported as zero might therefore become slightly greater than zero when examined with more sensitive technology.
That is technically interesting, but the clinical meaning requires restraint.
The established evidence behind coronary artery calcium scoring is based largely on conventional scanner technology, standardized acquisition protocols and outcome data collected over many years. Detecting a smaller speck of calcium does not automatically mean that all existing CAC risk categories should be discarded.
More sensitive detection may eventually improve risk assessment. It may also require revised thresholds, standardized protocols and new outcome data so that clinicians understand what newly visible findings mean.
There is another limitation to remember: a calcium score measures calcified plaque. It does not directly measure all noncalcified plaque. A CAC score of zero can substantially lower estimated risk without proving that the coronary arteries contain no atherosclerosis. A contrast-enhanced CCTA can provide information that a noncontrast calcium scan cannot.
Who May Benefit Most?
Photon-counting cardiac CT may be particularly helpful when conventional imaging is most likely to struggle, including patients with:
- Extensive coronary calcification
- Previously placed coronary stents
- Small coronary vessels
- Metallic cardiac devices or valve hardware
- A prior CCTA that was limited by image quality
- A clinical reason to minimize radiation or iodinated contrast when technically feasible
It may eventually become routine for a much broader population. For now, availability remains limited, protocols vary and experience matters.
Should Patients Wait for Photon-Counting CT?
Not necessarily.
A well-performed conventional CCTA remains capable of providing clinically useful information. Scan quality depends on more than the detector. Heart-rate control, patient movement, contrast timing, scanner protocol, reconstruction methods and the experience of the imaging team all influence the final result.
Delaying an appropriate evaluation solely because a photon-counting scanner is unavailable may not improve care. The decision depends on why the study is being ordered, the patient’s calcium burden, prior procedures, symptoms, underlying risk and whether the result is likely to change treatment.
When heavy calcium or coronary stents are already known to be present, it is reasonable to ask whether an imaging center has advanced cardiac CT capability and whether photon-counting technology could improve the likelihood of obtaining a diagnostic study.
The HormoneSynergy Perspective
Photon-counting CT appears to be a genuine technical advance, not simply a new label for an old scan. Its ability to improve coronary imaging through dense calcium and metal may address meaningful limitations of conventional CCTA.
Cleerly remains a different tool. It organizes and quantifies coronary disease after the scan has been completed. It may help physicians look beyond whether one artery appears narrowed and examine the larger burden and composition of plaque throughout the coronary tree.
The most promising model is therefore not photon-counting CT or Cleerly. It is high-quality image acquisition followed by validated analysis and careful clinical interpretation.
No scanner or algorithm decides what treatment is appropriate on its own. Results still need to be considered alongside symptoms, blood pressure, smoking history, metabolic health, family history, ApoB, lipoprotein(a), treatment tolerance and the patient’s broader risk profile.
Better imaging can provide better information. It cannot replace judgment about what to do with that information.
Related HormoneSynergy resources:
Frequently Asked Questions
Is photon-counting CT the same as Cleerly?
No. Photon-counting CT is scanner technology used to acquire CT images. Cleerly is software that analyzes images from a coronary CT angiogram.
Is photon-counting CT better than Cleerly?
They cannot be ranked in that way because they perform different jobs. Photon-counting CT may create clearer images. Cleerly evaluates those images for plaque, stenosis and other coronary findings.
Can Cleerly analyze a photon-counting CCTA?
Potential compatibility depends on the scanner, imaging protocol, reconstruction and the software platform’s validation requirements. The imaging center and ordering clinician should confirm that the study can be submitted and appropriately analyzed.
Does photon-counting CT eliminate calcium blooming?
It may substantially reduce calcium blooming, but no imaging technology eliminates every artifact in every patient. Scan quality and interpretation still depend on the protocol and clinical circumstances.
Can photon-counting CT find plaque when a calcium score is zero?
It may detect very small calcium deposits missed by conventional scanners. A contrast-enhanced CCTA can also detect certain noncalcified plaques that are not measured by a standard calcium score.
Should everyone request photon-counting CCTA?
Not at this time. It may be especially useful for heavy calcification, coronary stents or previously limited imaging. For many patients, a technically strong conventional CCTA remains appropriate.
Does a clearer scan automatically improve AI analysis?
Not automatically. Better images may help, but AI software must be validated on the scanner type and image characteristics being analyzed.
Sources and further reading:
- Cardiovascular Business: Photon-Counting CT vs. Conventional Detector Technologies
- Systematic Review: Photon-Counting CT Versus Energy-Integrating Detectors in Cardiovascular Imaging
- Photon-Counting CCTA and Calcium Blooming
- Cleerly Patient Education: How CCTA Analysis Works
- Cleerly Coronary Plaque Analysis
This article is part of the HormoneSynergy® Longevity Medicine education series covering preventive cardiology, metabolic health, hormone optimization, body composition, and advanced diagnostics for healthy aging.
Return to the Longevity Medicine Guide →